Fundraising Fox

Ossium Health

Delaware corporation · 7 known investors

ossiumhealth.com ↗

Ossium Health develops cellular therapies and bioengineered products for clinical use, leveraging adult stem cell technologies and advanced cell processing platforms. The company operates as a clinical-stage biotech firm manufacturing and distributing cellular therapeutics for patients with organ and tissue diseases.

BiotechHealthtechMedical Devicesin /ossiumhealth@OssiumHealth

Founders & leadership

KC
Kevin CaldwellCEO, Co-Founder & President
DW
Dr. WoodsChief Science Officer, Co-Founder, EVP, CLIA Laboratory Director
WT
William TrenchardDirector
SG
Sebastian GiwaDirector
TC
Thomas CycyotaDirector

Investors · 7

Hemisphere Ventures LLC
Manta Ray VenturesLondon
Vivo CapitalPalo Alto · $10M – $50M
XYZ Venture CapitalSan Francisco · $10K – $5M
FemHealth VenturesreportedShort Hills
First Round CapitalreportedSan Francisco · $2M
Village GlobalreportedCovina · $100K – $500K

Reported raises · per SEC filings

Form D private placements
▶$10.4MraisedMay 2018 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William TrenchardDirector
  • Kevin CaldwellExecutive Officer, Director
  • Erik WoodsExecutive Officer, Director
  • Sebastian GiwaDirector
  • Thomas CycyotaDirector
Offering amount
$10.4M
Amount sold
$10.4M
First sale
May 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.